Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis

H. M. Druce, S. Goldstein, J. Melamed, J. Grossman, B. A. Moss, R. G. Townley

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

An 8-week double-blind study was carried out in 177 ragweed patients with seasonal allergic rhinitis to compare nedocromil sodium 1% nasal solution (Tilarin(R), QID, Fisons plc) and placebo. Symptoms of rhinitis were significantly reduced by nedocromil sodium during the peak 3-week pollen season (P=.001 for diary summary score) and the active treatment was rated effective by 74% of patients.

Original languageEnglish
Pages (from-to)212-216
Number of pages5
JournalAnnals of Allergy
Volume65
Issue number3
StatePublished - 1990
Externally publishedYes

Fingerprint

Nedocromil
Ambrosia
Seasonal Allergic Rhinitis
Nose
Placebos
Rhinitis
Pollen
Double-Blind Method
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy

Cite this

Druce, H. M., Goldstein, S., Melamed, J., Grossman, J., Moss, B. A., & Townley, R. G. (1990). Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis. Annals of Allergy, 65(3), 212-216.

Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis. / Druce, H. M.; Goldstein, S.; Melamed, J.; Grossman, J.; Moss, B. A.; Townley, R. G.

In: Annals of Allergy, Vol. 65, No. 3, 1990, p. 212-216.

Research output: Contribution to journalArticle

Druce, HM, Goldstein, S, Melamed, J, Grossman, J, Moss, BA & Townley, RG 1990, 'Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis', Annals of Allergy, vol. 65, no. 3, pp. 212-216.
Druce HM, Goldstein S, Melamed J, Grossman J, Moss BA, Townley RG. Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis. Annals of Allergy. 1990;65(3):212-216.
Druce, H. M. ; Goldstein, S. ; Melamed, J. ; Grossman, J. ; Moss, B. A. ; Townley, R. G. / Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis. In: Annals of Allergy. 1990 ; Vol. 65, No. 3. pp. 212-216.
@article{15094fb0c5034611aaa8ab4104e4063e,
title = "Multicenter placebo-controlled study of nedocromil sodium 1{\%} nasal solution in ragweed seasonal allergic rhinitis",
abstract = "An 8-week double-blind study was carried out in 177 ragweed patients with seasonal allergic rhinitis to compare nedocromil sodium 1{\%} nasal solution (Tilarin(R), QID, Fisons plc) and placebo. Symptoms of rhinitis were significantly reduced by nedocromil sodium during the peak 3-week pollen season (P=.001 for diary summary score) and the active treatment was rated effective by 74{\%} of patients.",
author = "Druce, {H. M.} and S. Goldstein and J. Melamed and J. Grossman and Moss, {B. A.} and Townley, {R. G.}",
year = "1990",
language = "English",
volume = "65",
pages = "212--216",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "3",

}

TY - JOUR

T1 - Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis

AU - Druce, H. M.

AU - Goldstein, S.

AU - Melamed, J.

AU - Grossman, J.

AU - Moss, B. A.

AU - Townley, R. G.

PY - 1990

Y1 - 1990

N2 - An 8-week double-blind study was carried out in 177 ragweed patients with seasonal allergic rhinitis to compare nedocromil sodium 1% nasal solution (Tilarin(R), QID, Fisons plc) and placebo. Symptoms of rhinitis were significantly reduced by nedocromil sodium during the peak 3-week pollen season (P=.001 for diary summary score) and the active treatment was rated effective by 74% of patients.

AB - An 8-week double-blind study was carried out in 177 ragweed patients with seasonal allergic rhinitis to compare nedocromil sodium 1% nasal solution (Tilarin(R), QID, Fisons plc) and placebo. Symptoms of rhinitis were significantly reduced by nedocromil sodium during the peak 3-week pollen season (P=.001 for diary summary score) and the active treatment was rated effective by 74% of patients.

UR - http://www.scopus.com/inward/record.url?scp=0025031701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025031701&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 212

EP - 216

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 3

ER -